Lexeo Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 6.18 M | $35.50 M | 29.83% | 1.15% |
| BLACKROCK, INC. | 05/13/2026 | 5.11 M | $29.34 M | 4.14% | 0.95% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 5.05 M | $28.99 M | 57.82% | 0.94% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 5.00 M | $28.70 M | 0.00% | 0.93% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 4.98 M | $28.51 M | -9.68% | 0.93% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 4.48 M | $25.69 M | 0.00% | 0.83% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 4.42 M | $25.40 M | 0.00% | 0.82% |
| CITADEL ADVISORS LLC | 05/15/2026 | 3.83 M | $22.01 M | 1.61% | 0.71% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 3.60 M | $20.68 M | 69.53% | 0.67% |
| STATE STREET CORP | 05/15/2026 | 3.57 M | $20.48 M | 11.94% | 0.67% |
| 05/15/2026 | 3.01 M | $17.26 M | 100.00% | 0.56% | |
| WOODLINE PARTNERS LP | 05/15/2026 | 2.75 M | $15.79 M | -13.99% | 0.51% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.95 M | $11.19 M | 149.39% | 0.36% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 1.88 M | $10.76 M | -43.18% | 0.35% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 1.68 M | $9.65 M | -11.31% | 0.31% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.61 M | $9.26 M | 77.61% | 0.30% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 1.59 M | $9.12 M | -2.78% | 0.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.51 M | $8.69 M | 4.70% | 0.28% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 1.47 M | $8.42 M | 5.33% | 0.27% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.25 M | $7.18 M | 0.00% | 0.23% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.20 M | $6.89 M | 7.14% | 0.22% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.20 M | $6.89 M | 20.00% | 0.22% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.10 M | $6.33 M | 27.89% | 0.21% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 1.10 M | $6.31 M | -36.23% | 0.21% |
| 05/14/2026 | 928.59 K | $5.33 M | 430.62% | 0.17% | |
| BLACKSTONE INC. | 05/15/2026 | 904.96 K | $5.19 M | 0.00% | 0.17% |
| 05/08/2026 | 577.19 K | $3.31 M | 100.00% | 0.11% | |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 513.01 K | $2.94 M | 0.00% | 0.10% |
| NORTHERN TRUST CORP | 05/14/2026 | 493.67 K | $2.83 M | 8.01% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 491.53 K | $2.82 M | 206.66% | 0.09% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 465.52 K | $2.67 M | 249.34% | 0.09% |
| MORGAN STANLEY | 05/15/2026 | 402.92 K | $2.31 M | 187.43% | 0.08% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 384.73 K | $2.21 M | 100.00% | 0.07% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 377.06 K | $2.16 M | 10.62% | 0.07% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 339.62 K | $1.95 M | 0.66% | 0.06% |
| UBS GROUP AG | 05/05/2026 | 321.74 K | $1.85 M | 14.46% | 0.06% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 319.09 K | $1.83 M | 244.56% | 0.06% |
| ABRDN PLC | 04/29/2026 | 245.90 K | $1.41 M | 100.00% | 0.05% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 228.20 K | $1.31 M | -11.35% | 0.04% |
| PRIVIUM FUND MANAGEMENT B.V. | 05/05/2026 | 205.00 K | $1.18 M | 6.47% | 0.04% |
| NUVEEN, LLC | 04/30/2026 | 182.98 K | $1.05 M | -13.50% | 0.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 182.07 K | $1.05 M | -5.28% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 181.68 K | $1.04 M | -54.65% | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 172.70 K | $991.32 K | 107.50% | 0.03% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 158.90 K | $912.08 K | -4.71% | 0.03% |
| Y-INTERCEPT (HONG KONG) LTD | 04/27/2026 | 142.57 K | $818.36 K | -38.32% | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 136.38 K | $782.80 K | 0.00% | 0.03% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 125.00 K | $717.50 K | 0.00% | 0.02% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 112.98 K | $648.52 K | 331.15% | 0.02% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 112.17 K | $643.87 K | 100.00% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lexeo Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 166 institutional investors and hedge funds held shares of Lexeo Therapeutics Inc.. The most heavily invested institutionals were:
Paradigm Biocapital Advisors LP: 6.18 M
BlackRock, Inc.: 5.11 M
Affinity Asset Advisors, LLC: 5.05 M
RA CAPITAL MANAGEMENT, L.P.: 5 M
JANUS HENDERSON GROUP PLC: 4.98 M
Vestal Point Capital, LP: 4.48 M
14.89% of Lexeo Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 80.22 M shares in the last 24 months. This purchase volume represents approximately $596.86 M in transactions.